Skip to main content
Premium Trial:

Request an Annual Quote

Lab at Sea

Leonid Moroz at the University of Florida studies ctenophores, tiny muliticellular organisms that have nervous systems, but ones that are unlike any other nervous systems, reports Methagora, the Nature Methods blog. These and other interesting organisms live deep in the ocean, but bringing them back to the lab for study often means dealing with degraded samples.

"We cannot bring the sea to the lab, but we can bring a whole lab to the sea," Moroz tells Methagora.

With Ship-Seq — a ship outfitted with a sequencing lab — he has gone on two proof-of-principle voyages, one around Florida and the Bahamas and one to Palau.

At the suggestion of ship's captain, the researchers set up the lab within a shipping container, giving it a controlled environment. Moroz's lab at sea contains lab benches, anti-vibration tables, PCR machines, a water-purification system, and, of course, sequencers, namely the Life Technologies' Personal Genome Machine. The lab also has a satellite link to transfer data back to Florida.

For one of the trips, the scientist-sailors encountered roughs seas, Methagora notes. "People could not cope with the field conditions but the PGM machine could," Moroz says. Seasickness remedies are also on the lab's list of needed supplies.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.